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new techniques into standardized processing pipelines that 
can be used to reproducibly quantify tissue architecture. 
Major bottlenecks include the lack of robust staining, and 
adequate reconstruction and quantification techniques. To 
bridge this gap, we established protocols employing spe-
cific antibody combinations for immunostaining, confo-
cal imaging, three-dimensional reconstruction of approxi-
mately 100-μm-thick tissue blocks and quantification of 
key architectural features. We describe a standard proce-
dure termed ‘liver architectural staining’ for the simultane-
ous visualization of bile canaliculi, sinusoidal endothelial 
cells, glutamine synthetase (Gs) for the identification of 
central veins, and DAPI as a nuclear marker. Additionally, 
we present a second standard procedure entitled ‘s-phase 
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staining’, where s-phase-positive and s-phase-negative 
nuclei (stained with BrdU and DAPI, respectively), sinu-
soidal endothelial cells and Gs are stained. The techniques 
include three-dimensional reconstruction of the sinusoidal 
and bile canalicular networks from the same tissue block, 
and robust capture of position, size and shape of individual 
hepatocytes, as well as entire lobules from the same tissue 
specimen. In addition to the protocols, we have also estab-
lished image analysis software that allows relational and 
hierarchical quantifications of different liver substructures 
(e.g. cells and vascular branches) and events (e.g. cell pro-
liferation and death). Typical results acquired for routinely 
quantified parameters in adult mice (c57Bl6/N) include the 
hepatocyte volume (5,128.3 ± 837.8 μm3) and the fraction 
of the hepatocyte surface in contact with the neighbour-
ing hepatocytes (67.4 ± 6.7 %), sinusoids (22.1 ± 4.8 %) 
and bile canaliculi (9.9 ± 3.8 %). Parameters of the sinu-
soidal network that we also routinely quantify include the 
radius of the sinusoids (4.8 ± 2.25 μm), the branching 
angle (32.5 ± 11.2°), the length of intersection branches 
(23.93 ± 5.9 μm), the number of intersection nodes per 
mm3 (120.3 × 103 ± 42.1 × 103), the average length of 
sinusoidal vessel per mm3 (5.4 × 103 ± 1.4 × 103mm) 
and the percentage of vessel volume in relation to the 
whole liver volume (15.3 ± 3.9) (mean ± standard devia-
tion). Moreover, the provided parameters of the bile can-
alicular network are: length of the first-order branches 
(7.5 ± 0.6 μm), length of the second-order branches 
(10.9 ± 1.8 μm), length of the dead-end branches 
(5.9 ± 0.7 μm), the number of intersection nodes per 
mm3 (819.1 × 103 ± 180.7 × 103), the number of dead-
end branches per mm3 (409.9 × 103 ± 95.6 × 103), 
the length of the bile canalicular network per mm3 
(9.4 × 103 ± 0.7 × 103 mm) and the percentage of the bile 
canalicular volume with respect to the total liver volume 
(3.4 ± 0.005). A particular strength of our technique is that 
quantitative parameters of hepatocytes and bile canalicular 
as well as sinusoidal networks can be extracted from the 
same tissue block. reconstructions and quantifications 
performed as described in the current protocols can be used 
for quantitative mathematical modelling of the underlying 
mechanisms. Furthermore, protocols are presented for both 
human and pig livers. The technique is also applicable for 
both vibratome blocks and conventional paraffin slices.
Keywords systems biology · Quantitative imaging · 
confocal microscopy · liver microarchitecture · 
Hepatocyte polarity
Introduction
current studies in both cell biology and hepatology largely 
rely on imaging and image analysis of 2D pictures. How-
ever, many parameters of cell and tissue architecture can be 
better quantified using 3D reconstructions (Hoehme et al. 
2010; Braeuning et al. 2010). Unfortunately, the broad 
application of 3D imaging and image analysis is hampered 
by difficult-to-apply protocols (Godoy et al. 2013). To 
bridge this gap, we established methods for both imaging 
and automated analysis that encompasses staining, scan-
ning, reconstruction, quantification and modelling (Fig. 1). 
Earlier versions of the described techniques and analysis 
pipeline have already been applied leading to the identi-
fication of key mechanisms of liver regeneration (Höhme 
et al. 2007; Hoehme et al. 2010; schliess et al. 2014). This 
study primarily focuses on the reconstruction of sinusoidal 
networks. However, the current protocol also allows the 
simultaneous analysis of the intertwined sinusoidal and bile 
canalicular networks.
Purpose of the protocols
Architectural staining
 This protocol allows the visualization of bile canaliculi, 
sinusoidal endothelial cells and nuclei within the same 
tissue (Fig. 2). Moreover, glutamine synthetase (Gs), an 
enzyme exclusively expressed in approximately two hepat-
ocyte layers around the central vein (Fig. 2b), thus forming 
a ring around the central vein, is labelled to differentiate 
between central (Gs positive) and periportal (Gs negative) 
hepatocytes. The protocol describes the combined incuba-
tion of specific antibodies that directly target key archi-
tectural proteins of the liver. Anti-dipeptidyl peptidase IV/
cD26 (DPPIV/cD26) is used as a marker of the bile cana-
liculi, which are visualized by green fluorescence. Donkey 
anti-mouse (DMs) IgG is used to localize the hepatic sinu-
soids, which is labelled with red fluorescence and appears 
yellow when merged with the green channel (Fig. 2b, 
merge). Gs-positive hepatocytes around central veins 
are white (Fig. 2), and DAPI is used to counterstain the 
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nucleus. From larger tissue blocks comprising entire liver 
lobules (Fig. 2), individual hepatocytes can be extracted, 
and their relation to the adjacent bile canaliculi and sinu-
soids visualized and quantified (Fig. 3a). since DPPIV/
cD26 is also expressed in bile duct epithelial cells, the 
technique is also adequate to visualize how bile ducts are 
linked to the bile canalicular network via the canals of Her-
ing (Fig. 3b, c). 
Staining for visualization of S‑phases
This technique allows for the differentiation between 
s-phase-positive and s-phase-negative nuclei (Fig. 4). It is 
based on the principle that cells incorporate BrdU into their 
DNA during s-phase, which can then be visualized using 
anti-BrdU antibodies. s-phase-positive nuclei appear green, 
whereas the s-phase-negative cells show only blue fluo-
rescence due to DAPI staining. The sinusoidal endothelial 
cells appear red (Fig. 4), and the position of the central vein 
is identified by a ring of Gs-positive hepatocytes (white).
Image analysis protocols
Image analysis and quantification can be performed using 
our software TiQuant (www.msysbio.com/tiquant). This 
tool allows the quantitative analysis of key parameters of 
hepatocytes and the sinusoidal as well as bile canalicular 
networks (Table 1). The results in Table 1 are mean values 
and standard deviations from five mice (c57Bl6/N, male, 
8–12 weeks old). TiQuant quantifies large numbers of 
structures. For example, approximately 1.4 × 103 hepato-
cytes, 450 first-order sinusoidal branches and 950 second-
order bile canalicular branches are quantified in a single 
reconstructed tissue block at 20-fold magnification. These 
high numbers provide excellent conditions for statistical 
analyses. Moreover, all quantitative parameters of hepato-
cytes, sinusoids and bile canaliculi can be extracted from 
the same tissue specimen. Analysis of the ‘s-phase stain-
ing’ leads in a first step to the differentiation between 
BrdU-positive and BrdU-negative nuclei. As a result, fur-
ther hierarchical quantifications in relation to different 
Fig. 1  Imaging and analysis pipeline for reconstruction and quantification of liver microarchitecture
1164 Arch Toxicol (2014) 88:1161–1183
1 3
Fig. 2  liver architectural staining. a Examples of reconstructed 
mouse liver tissue. Blue nuclei, green: bile canalicular network and 
red: microvessel network. The scale bars are 100 μm. b raw data 
obtained from a confocal laser scanning microscope. Only an indi-
vidual slice level is shown. A routine z-stack of 75–100 μm includes 
approximately 180 such slice levels. Blue DAPI, green DPPIV/
cD26, red DMs and white Gs-positive hepatocytes. The scale bars 
are 100 μm. CV central vein, DMs donkey anti-mouse IgG, DAPI 
4′,6-diamidino-2-phenylindole, DPPIV dipeptidyl peptidase IV, GS 
glutamine synthetase (colour figure online)
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lobular structures are possible. For example, the fraction 
of BrdU-positive nuclei in relation to the distance of a 
necrotic lesion can be quantified (Fig. 1d). If this is per-
formed in mice at different time intervals after intoxication 
with a hepatotoxic compound, spatial–temporal profiles 
can be obtained illustrating preferential lobular regions and 
periods of proliferation (Hoehme et al. 2010).
Advantages and limitations
The advantages of the described methods are: (1) bile 
canaliculi and sinusoids can be reconstructed from the 
same tissue block, which normally encompasses an entire 
lobule (x-and y-axis) and the margins of the neighbouring 
lobules (depending on the dataset); (2) besides entire lob-
ules, detailed cell shape approximations and subcellular 
structures can also be visualized and quantified; (3) struc-
tures can be quantified in relation to their position within 
an individual lobule (e.g. periportal, mid-zonal and peri-
central); (4) s-phase positive cells can be quantified in rela-
tion to their lobular position; (5) variants of the protocols 
with distinct antibody combinations have been optimized 
to visualize liver tissue from humans, mice and pigs and 
to reproducibly quantify their architectural parameters; (6) 
the staining protocols can be performed either manually or 
using an automated system for high throughput; and (7) the 
technique has been established for approximately 100-μm-
thick vibratome slices. However, a modified version is also 
available for the staining of conventional paraffin sections.
A limitation of the technique is that staining vibratome 
slices thicker than 100 μm is still difficult with our tech-
nique due to limited antibody penetration. Therefore, the 
depth of the z-axis of the reconstructions is still smaller 
than the diameter of a liver lobule. Moreover, the resolution 
in the z-axis is worse when compared to the x- and y-axis. 
A further limitation of the described techniques is that they 
are more time consuming than conventional histology. Nev-
ertheless, based on the confocal microscopy data, full 3D 
reconstructions and quantifications are obtained within a 
few hours per tissue block by applying the described pro-
tocols and software. Moreover, approximately 90 % of this 
Fig. 3  a cell shape approximation of one hepatocyte (yellow) in rela-
tion to bile canaliculi (green) and sinusoids (red). such reconstruc-
tions can be obtained for individual cells from the larger tissue blocks 
shown in Fig. 2a. The scale bar is 30 μm. b Individual slice level of 
a z-stack showing a bile duct and a canal of Hering in the upper right 
corner. The scale bar is 50 μm. c reconstructions from the z-stacks 
level on the DPPIV/cD26 signal. The upper panel shows the recon-
structed raw data, whereas the bile duct (yellow) and Hering canal 
(white) are highlighted in the lower panel. The scale bars are 30 μm. 
BC bile canaliculi, BD bile duct, HC Hering canal, PV portal vein 
(colour figure online)
▸
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Fig. 4  s-phase visualization staining. a Examples of reconstructed 
mouse liver tissue. The green nuclei are s-phase (BrdU) positive. Blue: 
nuclei, green: s-phase-positive nuclei and red: microvessel (sinusoidal) 
network. The scale bars are 20 μm. b raw data were obtained from a 
confocal microscope. Only an individual slice level is shown. A routine 
z-stack of 75–100 μm includes approximately 180 such slice levels. 
Blue DAPI, green BrdU-positive nuclei, red DMs and white Gs-pos-
itive hepatocytes. The scale bars are 100 μm. BrdU bromodeoxyur-
idine, CV central vein, DAPI 4′,6-diamidino-2-phenylindole, DMs don-
key anti-mouse IgG, GS glutamine synthetase (colour figure online)
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time is fully automated and therefore can be parallelized 
which allows for high-throughput analyses if the computa-
tional power is available.
Quality control and validation
The technique for reconstruction of the bile canalicular and 
sinusoidal networks relies on an anti-mouse DPPIV/cD26 
antibody from goat. Therefore, we investigated the speci-
ficity of this antibody using DPPIV/cD26 knockout mice 
(Fig. 5a). The negative result in the knockout mice dem-
onstrates the specificity of the DPPIV/cD26 signal. The 
architectural staining protocol generates a yellow fluores-
cence signal for the sinusoidal endothelial cells (Fig. 5a, 
right panel, merge + DAPI). This signal reflects the merged 
green signal of DPPIV/cD26 and the red signal from the 
binding of the donkey anti-mouse IgG (DMs) antibody to 
the sinusoids. At first glance, this appears as an unneces-
sarily indirect way to visualize liver sinusoids, since anti-
bodies are available that specifically stain the sinusoidal 
endothelial cells, such as anti-IcAM1 (Fig. 6b). However, 
the anti-IcAM1 antibody is obtained from rabbit and is 
therefore generated in the same species as the antibody 
against glutamine synthetase. 
In order to visualize all structures (bile canaliculi, sinu-
soids and Gs-positive hepatocytes) in the same tissue, we 
present an optimized antibody combination—anti-DPPIV/
cD26, anti-Gs and secondary donkey anti-mouse IgG 
(DMs) antibodies. Anti-DPPIV/cD26 antibody labels 
both the bile canaliculi (Godoy et al. 2010; Hoehme et al. 
Table 1  Parameters routinely quantified from the reconstruction shown in Fig. 2a
Numbers are mean ± standard deviation from livers of five male, adult c57 Bl6/N mice
* The three contact areas do not add up to 100 but only 99.4 % for experimental reasons, because the antibodies leave a small fraction (less than 
1 %) of the hepatocyte surface unstained. Brief definition of some basic parameters: intersection node is a node in the network that is connected 
to more than two edges; first-order branch is a branch connecting two intersection nodes without disruption by a dead-end branch; second-order 
branch is a branch connecting two intersection nodes containing one or more than one dead-end branch in between; dead-end branch is a branch 
connected to the network by one end and unconnected at the other
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2010) and to a lesser degree, the sinusoidal endothelial 
cells of mice, an observation that has previously been 
reported for both rats and mice (rogler et al. 2007; Taran-
tola et al. 2012). To further validate the specificity of the 
DPPIV/cD26 antibody, we performed a co-staining with 
the bile canalicular multi-specific organic anion trans-
porter 1 (Mrp2 or cMOAT). Both proteins were shown to 
co-localize at the bile canaliculi (Fig. 6a). However, in con-
trast to Mrp2, DPPIV/cD26 was additionally expressed in 
the sinusoidal endothelial cells of mice as mentioned above 
(Figs. 5a, 6a). Anti-DPPIV/cD26 antibody was neverthe-
less selected for our routine architectural staining, mainly 
due to its commercial availability. The anti-Mrp2 (against 
mouse) used in the present study was kindly provided by 
B. stieger (supplemental table 1A), because the quality of 
all commercially available antibodies tested was inadequate 
for the current protocol. In our model, we used donkey 
anti-mouse IgG (DMs) to stain the endothelial sinusoids. 
We compared the staining signal of DMs to that of the 
endothelial-cell-specific antibody IcAM1 and observed a 
co-localization of the two signals (Fig. 6b). The principle 
of the architectural staining procedure can be based on the 
fluorescence of only two primary antibodies although three 
different colours (Fig. 7) visualize three different structures 
(bile canaliculi, sinusoids and pericentral hepatocytes). We 
initially tried to establish a technique based on three pri-
mary (anti-DPPIV/cD26, anti-IcAM1 or cD31 and anti-
Gs) and three secondary antibodies. However, this was 
not possible, because the 3 + 3 combination resulted in 
too high levels of background staining. In conclusion, the 
2 + 3 staining strategy (principle is shown in Fig. 7) was 
the only technique based on commercially available anti-
bodies that allowed the simultaneous and robust imaging of 
bile canaliculi, sinusoids and Gs-positive hepatocytes.
To test the specificity of the anti-glutamine synthetase 
(Gs) antibody, we used β-catenin knockout mice. since Gs 
expression is β-catenin dependent, these knockout mice are 
Gs negative (Braeuning et al. 2010; schreiber et al. 2011). 
No Gs-positive ring of hepatocytes was observed around 
the central veins in the knockout mice (Fig. 5b), demon-
strating the specificity of the anti-Gs antibody. However, 
despite the absence of the Gs-positive hepatocyte rings, 
a small number of solitary Gs-positive hepatocytes were 
observed. This is in agreement with our previous publica-
tions (Braeuning et al. 2010; schreiber et al. 2011) explain-
ing both phenotype and growth behaviour of these residual 
β-catenin-positive hepatocytes.
Fig. 5  Validation and quality control of the antibodies. a The 
DPPIV/cD26 staining is completely abolished in DPPIV knockout 
mice (DPPIV/cD26−/−). The scale bars are 50 μm. b The signal 
of Gs in a ring of pericentral hepatocytes is abolished in β-catenin 
knockout mice (β-catenin−/−). The scale bars are 100 μm. c The 
fraction of BrdU-positive nuclei (green) is low in control mice (1), 
high (approximately 30 %) in ccl4-exposed mice with BrdU injec-
tion (2) and absent in ccl4-treated mice without BrdU administration 
(3). The donkey anti-mouse IgG causes the red signal of the dead cell 
areas around the central veins. Therefore, this antibody can also be 
used to visualize necrotic regions. The scale bars are 100 μm. BrdU 
bromodeoxyuridine, CCl4 carbon tetrachloride, DMs donkey anti-
mouse IgG, DPPIV dipeptidyl peptidase IV, GS glutamine synthetase 
(colour figure online)
◂
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To analyse the specificity of the anti-BrdU (bromod-
eoxyuridine) antibody, we treated mice as follows: (i) no 
carbon tetrachloride (ccl4); injection of 80 mg/kg BrdU 
(i.p.) 1 h before liver preparation, (ii) 1.6 g/kg ccl4 to 
induce liver damage (48 h before preparation) plus 80 mg/
kg BrdU (i.p.) 1 h before liver preparation and (iii) 1.6 g/
kg ccl4 (48 h before preparation) but no injection of BrdU 
(Fig. 5c). The result shows low levels of BrdU-positive 
nuclei in (i), high levels (approximately 30 % BrdU posi-
tive) in (ii) and a completely negative staining in (iii). This 
convincingly demonstrates specificity of the anti-BrdU 
antibody. Architectural staining of the ccl4-damaged liver 
tissue also results in a red fluorescent signal at the peri-
central dead cell area (Fig. 5c, ii, iii), caused by the bind-
ing of the anti-DMs antibody to necrotic hepatocytes. This 
‘wanted side effect’ represents another advantage of using 
the anti-DMs antibody.
Application of the 3D protocol to further antibodies
Using the basic procedure described above for the ‘archi-
tectural staining’, the following already tested antibodies 
(suppl. Fig. 1) can be used with the same basic protocol by 
only exchanging the primary antibodies. The specific appli-
cation conditions are outlined in supplemental Tables 1a, 
b. Radixin can be used as a marker of the bile canaliculi 
(suppl. Fig. 1A). As a constituent of myosin, radixin binds 
to the basic canalicular structure, whereas DPPIV/CD26 and 
Mrp2 represent functional bile canalicular proteins where 
loss of expression can occur, for example under conditions 
of inflammation. β-Catenin can be used as a marker of the 
basolateral membrane of all hepatocytes (suppl. Fig. 1A). 
Collagen III stains the fibrotic streets found in mice treated 
with a ccl4 fibrogenic protocol (Nussler et al. 2014). label-
ling collagen III allows for the 3D reconstruction of fibrotic 
scars, which are rich in myofibroblasts (activated stellate 
cells). The latter can be visualized using alpha-smooth mus‑
cle actin (α-SMA) antibodies (suppl. Fig. 1A). Two anti-
bodies are particularly relevant for visualization of stellate 
cells; anti-desmin stains both activated and quiescent stel-
late cells while anti-α-SMA visualizes activated stellate cells 
only (suppl. Fig. 2). Both antibodies can be used to visu-
alize the strong accumulation of stellate cells in damaged 
liver tissue (suppl. Fig. 2). E-Cadherin can be used as a 
marker for the basolateral membranes of periportal hepato-
cytes (suppl. Fig. 1B). The low-density lipoprotein receptor 
(LDL-R) also stains the basolateral membrane but the signal 
is homogenous throughout the liver lobule (suppl. Fig. 1B). 
Both ICAM1 and lectin can be used to identify sinusoidal 
endothelial cells (suppl. Fig. 1B). While ICAM1 is specific 
for sinusoidal endothelial cells, lectin additionally binds to 
the hepatocyte membrane and therefore represents a robust 
technique to visualize the surface of the hepatocyte. Ki-67 
and alpha-tubulin are both markers of cell cycle progression 
(suppl. Fig. 1c). While Ki-67 is expressed by hepatocytes in 
G1-, s-, G2- and M-phases of the cell cycle, alpha-tubulin 
Fig. 6  Validation of the DPPIV/cD26 and donkey anti-mouse IgG 
antibodies. a DPPIV/cD26 co-localizes with Mrp2. However, Mrp2 
exclusively stains the bile canaliculi, whereas DPPIV/cD26 is also 
visible in the sinusoidal endothelial cells. The scale bars are 50 μm. b 
In architectural staining, donkey anti-mouse IgG (DMs) is used to vis-
ualize the sinusoidal endothelial cells. co-staining with DMs (red) and 
the endothelial marker IcAM1 (white) shows good co-localization. 
The scale bars are 100 μm. DMs donkey anti-mouse IgG, DPPIV 
dipeptidyl peptidase IV, ICAM1 intercellular adhesion molecule-1, 
Mrp2 multi-drug resistance-associated protein 2 (colour figure online)
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exclusively labels the mitotic spindle and can be used to 
analyse the spindle orientation in relation to the closest sinu-
soid or the apical membrane (Hoehme et al. 2010). Further 
markers are the tight junction protein claudine 1 and the 
export pump Mrp2—both present in bile canaliculi (suppl. 
Fig. 1c).
Fig. 7  Principle of the ‘archi-
tectural staining’ for simultane-
ous visualization of the bile 
and sinusoidal networks as well 
as pericentral (Gs positive) 
hepatocytes. CV central vein, 
DPPIV dipeptidyl peptidase IV, 
GS glutamine synthetase
Fig. 8  The staining and reconstruction techniques can also be 
applied for human and pig livers. The standard procedure ‘architec-
tural staining’ can be used with the exception that the first and sec-
ondary antibodies have to be exchanged as described in supplemental 
Table 1a, b. It should be considered that the stainings shown in all 
other figures represent mouse livers. The scale bars are 100 μm
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Application of the protocols to vibratome blocks of human 
and pig livers
All analyses presented so far (Figs. 1, 2, 3, 4, 5, 6, 9) were 
performed using mouse livers. However, the ‘architectural 
staining’ protocol can also be applied with liver tis-
sue from humans and pigs. The required antibodies and 
incubation conditions are summarized in supplemental 
tables 1A and 1B. The anti-human DPPIV/cD26 anti-
body from goat exclusively stains bile canaliculi in liver 
Fig. 9  The protocols can also be applied to conventional paraf-
fin slices with minor modifications as described under ‘protocol for 
immunostaining of paraffin sections’. a Immunostaining of DPPIV/
cD26, BrdU, Ki-67, Gs and E-cadherin antibodies. Scale bars are 
100 μm in the upper images and 200 μm in the lower. b Whole-slide 
scans of paraffin sections stained for Gs or BrdU. Scale bars are 
1,000 μm. BrdU bromodeoxyuridine, DPPIV dipeptidyl peptidase IV, 
GS glutamine synthetase
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tissue of humans and pigs, but not sinusoidal endothelial 
cells (Fig. 8, upper left panel). The specificity is different 
in mice where DPPIV/cD26 is expressed in both the bile 
canaliculi and sinusoidal endothelial cells. To visualize 
the sinusoidal endothelial cells, an anti-human cD31 anti-
body from mouse is used (Fig. 8, upper middle panel). The 
merged image shows bile canaliculi in green and sinusoids 
in red (Fig. 8, upper right panel). Based on the described 
staining protocols, similar reconstructions and quantifica-
tions as described for mouse liver tissue can be applied to 
human and pig livers.
The anti-human DDPIV/cD26 antibody, used to detect 
the human protein, also recognizes pig DPPIV/cD26. 
Anti-human DPPIV/cD26 exclusively labels the bile 
canaliculi and not the sinusoidal endothelial cells (Fig. 8, 
lower left panel). Unfortunately, the anti-human cD31 
is not suitable for pig liver (data not shown). Therefore, 
sinusoidal endothelial cells must be visualized using bioti-
nylated lectin (Fig. 8, lower middle panel). The merged 
image shows both structures, bile canaliculi in green and 
the sinusoids in red (Fig. 8, lower right panel). comparing 
architectural stainings from mice (Fig. 2), human and pigs 
(Fig. 8), it becomes obvious that the lumen of the human 
and pig sinusoids is larger compared with that of mice. 
A systematic quantification of interspecies differences 
of the liver microarchitecture will be addressed in a later 
publication.
Application of the protocols to paraffin-embedded material
All the stainings presented so far have been done with 
approximately 100-μm-thick vibratome blocks (Figs. 1, 2, 
3, 4, 5, 6, 8). The advantage of a vibratome block is the 
possibility to reconstruct 3D bile canalicular and sinusoi-
dal networks. However, the standard ‘architectural stain-
ing protocol’ can be also applied to conventional paraffin 
slices. Minor modifications of the standard protocol are 
described under ‘protocol for immunostaining of paraf-
fin sections’. A limitation of using paraffin sections is that 
only two-dimensional imaging is possible (Fig. 9a). con-
versely, the sections can be advantageous because whole-
slide tissue scans can be obtained as illustrated for Gs 
and BrdU in Fig. 9b. In principle, such whole-slide scans 
offer the possibility of automated analysis of a very high 
number of structures leading to vastly improved statistical 
power.
Protocols
All buffers and reagents are described under ‘general 
remarks and reagents’.
Preparation of vibratome liver section for immunostaining
1. Fix liver lobes in roti®-Histofix 4 % (cArl-rOTH, 
Karlsruhe, Germany, P087.1) for 3 days at 4 °c. Do 
not cut lobes into smaller pieces. Avoid squeezing of 
the liver tissue during preparation.
2. store tissue sections in reagent B at 4 °c. In this rea-
gent, liver tissue can be stored up to 6 months.
3. Immediately before staining, slice the liver lobe parallel to 
its surface using a vibrating blade microtome (Vibratome 
VT1000 s, leica, Wetzlar, Germany) as follows:
3.1. Fix the liver lobe in the specimen holder using 
glue (Histoacryl®Gewebekleber, B.Braun GmbH, 
Melsungen, Germany, 9381104) and wait for 
2 min. Install the buffer tray and specimen holder 
in the vibratome.
3.2. Pour reagent A into the buffer tray until the liver 
lobe is covered.
3.3. Fix the vibratome feather blades (blades 
VT, leica Microsystems, Wetzlar, Germany, 
14020542056) tightly into the knife holder and 
install into the vibratome. Press the start button.
3.4. Adjust the slicing settings to 75–100 μm thick-
ness and low velocity.
Protocol for liver architectural staining (example of a 
result: Figs. 2 and 3)
This protocol describes a staining technique for visualiza-
tion of the liver microarchitecture including bile canali-
cular and sinusoidal networks. Moreover, the pericentral 
hepatocytes are identified by a positive Gs signal, which 
allows localization of the central veins. Nuclei are stained 
with DAPI. A modified version for paraffin sections, 
using the same antibodies, is described in the subsequent 
section.
samples: 75–100-μm vibratome liver sections that are 
stored in reagent B at 4 °c.
First day
1. Wash tissue sections three times for 10 min each in 
reagent A at room temperature.
2. Antigen de-masking:
2.1 Add 400 ml of reagent c into a 500-ml plastic 
jar, cover and heat for 2 min in a microwave oven 
(sharp Electronics, UK—95 °c).
2.2 Pipette 2 ml of heated reagent c into each well of 
a 24-well tissue culture plate (sArsTEDT, Num-
brecht, Germany, 83.1836).
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2.3 remove tissue sections from reagent A and 
immerse in heated reagent c (in the 24-well tis-
sue culture plate) for 2 min.
2.4 During the 2-min incubation, reheat reagent c 
(left in the plastic jar) again for 2 min and repeat 
steps 2.2. and 2.3. for an additional 9 times.
2.5 cool tissue sections for 20 min at room tempera-
ture.
3. Wash tissue sections three times for 10 min each in 
reagent A at room temperature.
4. Blocking serum step:
4.1 Pipette 1 ml of reagent E into each well of a 
24-well tissue culture plate.
4.2 remove tissue sections from reagent A and 
immerse in reagent E.
4.3 Incubate tissue sections in reagent E for 2 h at 
room temperature in a 24-well tissue culture 
plate.
5. Primary antibodies:
5.1 Dilute rabbit anti-glutamine synthetase (sigma-
Aldrich, Missouri, UsA, G2781, 1:2,000) and 
goat anti-mouse DPPIV/cD26 ectodomain (r&D 
systems, Minneapolis, MN, UsA, AF954, 1:100) 
in reagent F in a 15-ml tube.
5.2 Pipette 1 ml of the diluted antibodies (from step 
5.1.) into each well of a 24-well tissue culture 
plate.
5.3 remove tissue sections from reagent E and 
immerse in the diluted antibodies.
5.4 Incubate tissue sections in the diluted antibodies 
overnight at 4 °c.
Second day
6. Wash tissue sections three times for 10 min each in 
reagent A at room temperature.
7. secondary antibodies:
7.1 Dilute alexafluor®488-conjugated AffiniPure 
F(ab’)2 fragment donkey anti-goat IgG (H + l) 
(Dianova GmbH, Hamburg, Germany, 705-
546-147, 1:100), cyTM3-conjugated AffiniPure 
F(ab’)2 fragment donkey anti-rabbit (Dianova 
GmbH, Hamburg, Germany, 711-166-152, 
1:200) and alexafluor®647-conjugated Affin-
iPure F(ab’)2 fragment donkey anti-mouse (DMs, 
Dianova GmbH, Hamburg, Germany, 715-606-
150, 1:500) in reagent F in a 15-ml tube.
7.2 Pipette 1 ml of the diluted antibodies (from step 
7.1.) into each well of a 24-well tissue culture 
plate.
7.3 remove tissue sections from reagent A and 
immerse in the diluted antibodies.
7.4 Incubate tissue sections in the diluted antibodies 
overnight at 4 °c.
Third day
8. Wash tissue sections three times for 10 min each in 
reagent A at room temperature.
9. counterstaining:
9.1 Prepare DAPI (4′,6-diamidin-2-phenylindol) 
solution as follows: To 10 ml of distilled water, 
add 1 μl of DAPI (Invitrogen, Darmstadt, Ger-
many, D3571) and mix well.
9.2 Pipette 1 ml of the diluted DAPI (from step 9.1.) 
into each well of a 24-well tissue culture plate.
9.3 remove tissue sections from reagent A and 
immerse in the diluted DAPI.
9.4 Incubate tissue sections with DAPI for 90 min at 
room temperature.
10. Wash tissue section three times for 10 min each in rea-
gent A at room temperature.
11. Wash tissue sections for 10 min in distilled water at 
room temperature.
12. Mount tissue sections on a microscope slide (super 
frost plus, Thermo scientific, Gerhard Menzel GmbH, 
Braunschweig, Germany, Art. No. J1800AMNZ) using 
FluorPreserve reagent (Merck; cat. No. 345787), 
cover with microscope cover glass (Thermo scientific, 
Gerhard Menzel GmbH, Braunschweig, Germany, 
18 × 18 mm, 165027) and allow slides to dry in the 
dark.
Protocol for s-phase visualization (example of a result: 
Fig. 4)
This protocol describes a staining technique for visualiza-
tion and quantification of hepatocytes and non-parenchy-
mal cells in s-phase. The protocol also visualizes the sinu-
soids and the pericentral hepatocytes (by Gs staining). The 
nuclei are stained with DAPI.
samples: 75–100-μm vibratome sections kept in reagent 
B at 4 °c.
First day
1. Wash tissue sections three times for 10 min each in 
reagent A at room temperature.
2. Antigen de-masking:
2.1. Pipette 1.25 ml of reagent c into a 2-ml Eppen-
dorf tube (Micro-tube, sArsTEDT, Numbrecht, 
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Germany, 72.695.500) and immerse tissue sec-
tions in reagent c.
2.2. cook tissue sections in reagent c using a Therm-
oMixer (Model HTM 130l, Hlc Biotech, Bov-
enden, Germany) at 95 °c for 25 min with shak-
ing.
2.3. cool tissue sections for 20 min at room tempera-
ture.
3. Wash tissue sections three times for 10 min each in 
reagent A at room temperature.
4. Hcl digestion:
4.1. Pipette 2 ml of reagent D into each well of a 
24-well tissue culture plate (sArsTEDT, Num-
brecht, Germany, 83.1836).
4.2. remove tissue sections from reagent A and 
immerse in reagent D.
4.3. Incubate tissue sections in reagent D for 10 min 
at room temperature.
5. Wash tissue sections three times for 10 min each in 
reagent A at room temperature.
6. Blocking serum step:
6.1. Pipette 1 ml of reagent E into each well of a 
24-well tissue culture plate.
6.2. remove tissue sections from reagent A and 
immerse in reagent E.
6.3. Incubate tissue sections in reagent E for 2 h at 
room temperature in a 24-well tissue culture 
plate.
7. First Primary antibody:
7.1. Dilute rat anti-BrdU, clone BU1/75 (Icr1) (AbD 
sErOTEc, Düsseldorf, Germany, McA2060, 
1:500) in reagent F in a 15-ml tube.
7.2. Pipette 1 ml of the diluted antibodies (from step 
7.1.) into each well of a 24-well tissue culture 
plate.
7.3. remove tissue sections from reagent E and 
immerse in the diluted antibodies.
7.4. Incubate tissue sections in the diluted antibodies 
overnight at 4 °c.
Second day
8. Wash tissue sections three times for 10 min each in 
reagent A at room temperature.
9. First secondary antibody:
9.1 Dilute alexafluor®488-conjugated AffiniPure 
F(ab’)2 fragment donkey anti-rat IgG (H + l) 
(Dianova GmbH, Hamburg, Germany, 712-546-
150, 1:200) in reagent F in a 15-ml tube.
9.2 Pipette 1 ml of the diluted antibodies (from step 
9.1.) into each well of a 24-well tissue culture 
plate.
9.3 remove tissue sections from reagent E and 
immerse in the diluted antibodies.
9.4 Incubate tissue sections in the diluted antibodies 
overnight at 4 °c.
Third day
10. Wash tissue sections three times for 10 min each in 
reagent A at room temperature.
11. second primary antibody:
11.1 Dilute rabbit anti-glutamine synthetase (sigma-
Aldrich, Missouri, UsA, G2781, 1:2,000) in rea-
gent F in a 15-ml tube.
11.2 Pipette 1 ml of the diluted antibodies (from step 
11.1.) into each well of a 24-well tissue culture 
plate.
11.3 remove tissue sections from reagent E and 
immerse in the diluted antibodies.
11.4 Incubate tissue sections overnight at 4 °c.
Fourth day
12. Wash tissue sections three times for 10 min each in 
reagent A at room temperature.
13. second secondary antibodies:
13.1 Dilute cy™3-conjugated AffiniPure F(ab’)2 
fragment donkey anti-rabbit (Dianova GmbH, 
Hamburg, Germany, 711-166-152, 1:200) and 
alexafluor®647-conjugated AffiniPure F(ab’)2 
fragment donkey anti-mouse (DMs, Dianova 
GmbH, Hamburg, Germany, 715-606-150, 1:500) 
in reagent F in a 15 ml tube.
13.2 Pipette 1 ml of the diluted antibodies (from step 
13.1.) into each well of a 24-well tissue culture 
plate.
13.3 remove tissue sections from reagent E and 
immerse in the diluted antibodies.
13.4 Incubate tissue sections in the diluted antibodies 
overnight at 4 °c.
Fifth day
14. Wash tissue sections three times for 10 min each in 
reagent A at room temperature.
15. counterstaining:
15.1 Prepare DAPI (4′,6-diamidin-2-phenylindol) 
solution as follows: To 10 ml of distilled water, 
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add 1 μl of DAPI (Invitrogen, Darmstadt, Ger-
many, D3571) and mix well.
15.2 Pipette 1 ml of the diluted DAPI (from step 15.1.) 
into each well of a 24-well tissue culture plate.
15.3 remove tissue sections from reagent A and 
immerse in the diluted DAPI.
15.4 Incubate tissue sections with DAPI for 90 min at 
room temperature.
16. Wash tissue section three times for 10 min each in rea-
gent A at room temperature.
17. Wash tissue sections for 10 min in distilled water at 
room temperature.
18. Mount tissue sections on microscope slides (super 
frost plus, Thermo scientific, Gerhard Menzel GmbH, 
Braunschweig, Germany, Art. No. J1800AMNZ) using 
FluorPreserve reagent (Merck; cat. No. 345787), 
cover with microscope cover glass (Thermo scientific, 
Gerhard Menzel GmbH, Braunschweig, Germany, 
18 × 18 mm, 165027) and allow slides to dry in the 
dark.
General remarks and reagents
General remarks
1. During slicing, discard the first and last tissue sections 
to avoid the margin of a tissue block where the struc-
ture often appears altered.
2. All incubation and washing steps should be done on a 
shaker (Type Kl2, Edmund Buhler GmbH, Hechingen, 
Germany, Nr. 6115, approx. 200 movements).
3. Prepare all antibodies and DAPI directly prior to use.
4. Prepare antibodies, buffers and DAPI in 0.5-ml Eppen-
dorf (Micro-tube, sArsTEDT, Numbrecht, Germany, 
72.704.00) or 1.5-ml Eppendorf vials (Micro-tube, 
sArsTEDT, Numbrecht, Germany, 72.706) or in 
a 15-ml tube (sArsTEDT, Numbrecht, Germany, 
62.554.502) or a 50-ml tube (sArsTEDT, Numbrecht, 
Germany, 62.547.254).
5. Incubate tissue sections overnight in 24-well tissue 
culture plates (sArsTEDT, Numbrecht, Germany, 
83.1836.300).
6. Use 1 ml of reagent per well of a 24-well plate.
reagents
Reagent A (1× PBS)
1. For 5 l of 10× PBs:
1.1 To 4 l of distilled water, add 10 g of potassium 
chloride (Kcl, cArl-rOTH, Karlsruhe, Ger-
many, Art.-Nr. 6781.1), 10 g of potassium dihy-
drogen phosphate (KH2PO4, cArl-rOTH, 
Karlsruhe, Germany, Art.-Nr. 3904.1), 400 g of 
sodium chloride (Nacl, cArl-rOTH, Karlsruhe, 
Germany, Art.-Nr.3957.2) and 46 g of diso-
dium hydrogen phosphate anhydrous (Na2HPO4, 
cArl-rOTH, Karlsruhe, Germany, Art.-Nr. 
P030.2) and mix well to dissolve.
1.2 Adjust the pH of the solution to 7.4.
1.3 Bring the volume to 5 l with distilled water.
2. For 1 l of 1× PBs:
2.1 To 900 ml of distilled water, add 100 ml of pre-
pared 10× PBs and mix well.
Reagent B (preservation buffer)
1. To 1,000 ml of reagent A, add 300 g of glucose 
(D-(+)-glucose anhydrous, cArl-rOTH, Karlsruhe, 
Germany, Art.-Nr. X997.2) and mix well.
2. To 100 ml of the prepared glucose (in step 1), add 
100 ml of roti®-Histofix 4 % (cArl-rOTH, 
Karlsruhe, Germany, P087.1) and mix well.
3. store reagent B at 4 °c.
Reagent C (antigen retrieval)
1. To 800 ml of distilled water, add 2.1 g of citric acid 
monohydrate (cArl-rOTH, Karlsruhe, Germany, Art. 
3958.2) and mix well.
2. Adjust the pH of the solution to 6.0.
3. Bring the volume to 1 l with distilled water.
Reagent D (DNA denaturation agent)
1. Prepare 2N hydrochloric acid (Hcl, 4 mol/l, cArl-
rOTH, Karlsruhe, Germany, Art.Nr.NO76.1) as follows: 
To 10 ml of distilled water, add 10 ml of Hcl and mix 
well.
Reagent E (blocking buffer)
1. To 97 ml of reagent A, add 3 g of bovine albumin frac-
tion V, protease free (BsA, serva Electrophoresis GmbH, 
Heidelberg, Germany, 11926, 100 g) and mix well.
2. Add 3 ml of Tween80 (sigma-Aldrich, schnelldorf, 
Germany, P8074, 500 ml) and mix well.
3. Prepare 10 ml aliquots and store at −20 °c.
Reagent F (dilution buffer)
1. To 97 ml of 1× PBs, add 0.3 g of bovine albumin 
fraction V, protease free (BsA, serva Electrophoresis 
GmbH, Heidelberg, Germany, 11926, 100 g) and mix 
well.
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2. Add 3 ml of Tween80 (sigma-Aldrich, schnelldorf, 
Germany, P8074, 500 ml) and mix well.
3. Prepare 10 ml aliquots and store at −20 °c.
Protocol for immunostaining of paraffin sections (example 
of a result: Fig. 9)
This protocol describes a staining technique for paraffin 
liver sections.
samples: 5–8 μm paraffin-embedded sections.
 1. De-paraffinize the sections in four washes of roti-his-
tol (carl-rOTH; Karlsruhe-Germany; Art. No. 6640) 
for 5 min each.
 2. rehydrate the sections using descending ethanol (carl-
rOTH; Karlsruhe-Germany; Art. No. 9065.4) gradients 
(100, 95, 90, 70, 50 and 30 % ethanol, for 5 min each).
 3. Wash the sections once in distilled water for 5 min.
 4. Unmask the antigen of interest using an acid and heat 
treatment as follows:
4.1 Place the sections in a container, cover with freshly 
prepared reagent c and heat at 95 °c for 7 min in a 
microwave oven (sharp Electronics, UK).
4.2 Top off with reagent c and reheat at 95 °c for 
7 min.
4.3 Allow the sections to cool in the heated reagent c 
for approximately 20 min.
 5. Wash the sections in reagent A three times for 5 min 
each.
 6. Block the endogenous peroxidase by a methanolic 
hydrogen peroxide (H2O2) treatment. For 100 ml of 
30 % H2O2 (carl-rOTH; Karlsruhe-Germany; Art. 
No. 8070.4), add 100 ml of methanol (J.T.Baker; 
Griesheim-Germany; JT9093-3) and incubate the sec-
tions in the methanolic H2O2 for 30 min at room tem-
perature in a dark box.
 7. Wash the sections in reagent A three times for 5 min 
each.
 8. Block any unspecific binding using reagent E. 
remove the sections from reagent A and immerse in 
reagent E. Incubate the sections in reagent E for 1 h at 
room temperature in a humified chamber.
 9. Drain the blocking solution from the slides and apply 
two drops of avidin solution (Avidin biotin block-
ing kit; Vector laboratories; Dossenheim-Germany; 
sP2001) for 15 min.
 10. remove the avidin solution from the slides and apply 
two drops of biotin solution (Avidin biotin block-
ing kit; Vector laboratories; Dossenheim-Germany; 
sP2001) for 15 min.
 11. Drain the biotin solution from slides.
 12. Apply approximately 200 μl of the diluted primary 
antibody (in reagent F) at the recommended concen-
tration per slide (supplemental table 1A) and incubate 
the sections overnight at 4 °c.
 13. Wash the sections in reagent A three times for 5 min 
each.
 14. Apply approximately 200 μl of the diluted second-
ary biotinylated antibody (in reagent F) at the rec-
ommended concentration per slide (supplemental 
table 1B) and incubate the sections for 60 min.
 15. Wash the sections in reagent A three times for 5 min 
each.
 16. Apply approximately 200 μl of the diluted horse-
radish peroxidase (in reagent F) at the recommended 
concentration per slide (supplemental Table 1B) and 
incubate the sections for 60 min.
 17. Wash the sections in reagent A three times for 5 min 
each.
 18. Prepare the 3,3′-diaminobenzidine (DAB) peroxidase 
substrate (Vector laboratories; Dossenheim-Ger-
many; sK-4100) as follows:
18.1 To 5.0 ml of distilled water, add 2 drops of the 
buffer stock solution and mix well.
18.2 Add 4 drops of the DAB stock solution and mix 
well.
18.3 Add 2 drops of the hydrogen peroxide solution 
and mix well.
18.4 Incubate the sections with the substrate working 
solution at room temperature for 4 min.
18.5 Wash the sections once in distilled water for 
5 min.
 19. counterstain the sections in Mayer’s haematoxy-
lin (Merck, langenfeld-Germany; art. Number: 
1092492500) for 120 s and immediately wash the sec-
tions under tap water for 10 min.
 20. Dehydrate the sections using ascending ethanol (carl-
rOTH; Karlsruhe-Germany; Art. No. 9065.4) gradi-
ents (30, 50, 70, 90, 95 and 100 % ethanol, for 10 s 
each).
 21. Wash the sections twice in roti-histol (carl-rOTH; 
Karlsruhe-Germany; Art. No. 6640) for 3 min each.
 22. Mount the sections on microscope slides (super frost 
plus, Thermo scientific, Gerhard Menzel GmbH, 
Braunschweig, Germany, Art.No.J1800AMNZ) using 
Entellan (Merck-Millipore, Darmstadt-Germany; cat. 
No. 1079600500), cover with microscope cover glass 
(Thermo scientific, Gerhard Menzel GmbH, Braun-
schweig, Germany, 18 × 18 mm, 165027) and allow 
slides to dry in the dark.
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confocal scanning microscopy and z-stack image 
acquisition
To reconstruct and quantify liver tissue, a confocal laser 
scanning microscope (Olympus, Germany, FV1000) was 
used and z-stacks were generated as follows:
1. cover the tissue slice with one drop of Olympus immer-
sion oil type-F (Olympus, Japan, IMMOIl-F30cc).
2. Prepare the z-stacks by 20× or 60× oil objectives (the 
settings are described in supplemental table 2).
3. Adjust the parameters of the scanning mode as 
described in supplemental table 2.
4. select the corresponding dyes from the dye list. For 
architectural staining, select DAPI (blue; nuclear stain-
ing), alexafluor 488 (green; DPPIV/cD26 signal), cy3 
(white; Gs staining) and Alexafluor 647 (red; DMs 
channel).
5. stop the pre-scan mode and activate the 3D scanning 
mode.
6. Define the scanable first and the last z-levels.
7. Press the ‘start’ button to start manual recording, 
adjust the laser energy settings (HV, gain and offset) to 
approximately every 1 μm of z-level and record each 
level.
8. Press the ‘end’ button and start the automatic recording 
mode.
9. Deconvolute the 3D image using AutoQuant X3 (Bit-
plane). The 3D image is then ready for the pre-process-
ing steps as described in the ‘Image Processing with 
TiQuant’ section.
Image analysis protocols
The TiQuant software is used for image processing of 
multi-cellular tissues. It uses the open-source image pro-
cessing and visualization libraries Insight segmentation 
and registration Toolkit (ITK) and Visualization Toolkit 
(VTK), as well as Qt, OpenGl/GlUT and HDF5. simi-
lar to its precursor software (Hoehme and Drasdo 2010), 
TiQuant will become part of an open-source software 
framework which also includes modelling and simulation 
capabilities. This software framework is able to receive 
input directly from the image processing and analysis tool 
provided in this paper.
Equipment setup
1. A computer (64 bit, preferably multi-processor, mini-
mum of 16 GB rAM, 50 MB free disc space) with a 
Unix/linux or Microsoft Windows operating system.
2. Installation of TiQuant, which is available from our 
homepage (www.msysbio.com/tiquant).
3. Installation of image processing software capable of 
reading and visualizing 3D image stacks (e.g. ImageJ).
4. Digitized image stacks in TIFF format prepared 
according to the above-described staining protocols 
comprising DAPI, DPPIV/cD26, Gs and DMs chan-
nels, imaged using the 60× objective at a voxel resolu-
tion of 0.207 μm × 0.207 μm × 0.54 μm and 1,024 
pxl × 1,024 pxl in x–y dimension. This set-up shows a 
fraction of one hepatic lobule.
5. Imaging set-ups meant for the analysis of a complete 
lobule should be imaged with a 20× objective at a 
voxel resolution of 0.621 μm × 0.621 μm × 0.54 μm 
and 1,024 pxl × 1,024 pxl.
Image processing with TiQuant
The current version of TiQuant implements a number of so-
called image processing pipelines tailored for the segmen-
tation and quantification of veins, hepatic and non-hepatic 
nuclei, sinusoidal and bile canaliculi networks, as well as 
hepatocytes and necrotic tissue in 3D, which are obtained 
by confocal microscopy of liver lobules. These process-
ing pipelines essentially are sequences of image filters and 
algorithmic units that can be parameterized to compensate 
for image feature variability. The following sections intro-
duce all processing pipelines and their parameters in a way 
that will enable users not familiar with image processing to 
work with the software.
Quick guide to TiQuant’s graphical user interface
The user interface of TiQuant is split into two functional 
panels.
In the left panel, the processing pipeline selection menu 
is located (first button in the left panel), as well as buttons 
for starting a pipeline, adding pipeline ‘jobs’ to a queue, 
and starting the latter.
In the right panel, a table is shown that allows for param-
eterization of the currently selected pipeline. Parameter val-
ues are editable by double clicking in the corresponding 
field in the ‘Value’ column. In case the parameter is a file-
name, a double click will enable a small button in the value 
field, which will open a file browser.
After adjustment of all parameters, a pipeline can be 
either started by clicking ‘start pipeline’ or added to a pro-
cessing queue by clicking ‘Add Job’ in the left panel. The 
latter will not start the pipeline immediately, but queue it 
for later sequential processing. When all jobs have been 
added, processing of the queue can be started by clicking 
the ‘start queued jobs’ button.
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Workflow
To ensure segmentation and quantification of results that 
are of high and reproducible quality, it is necessary to fol-
low an iterative procedure.
First, all channels of a dataset that are meant to be used 
for segmentation have to be thoroughly examined and 
assessed for quality. It is imperative that structures to be 
segmented are clearly visible and are set apart from the 
background throughout the whole dataset. If a lack of 
staining or high background noise compromises a con-
siderably large part of the dataset, then the dataset may 
not be suitable for quantification. If the dataset is of suf-
ficient quality for quantification, it is recommended that 
after pre-processing, to use the default parameter set of a 
processing pipeline be used to yield an initial segmenta-
tion. After execution, the quality of the result has to be 
assessed. For this purpose, each pipeline produces a file 
ending with the suffix ‘_overlay’, which is an overlay of 
the segmented structures over the raw data. In addition, 
the segmentation is saved as a binary mask with the file 
ending ‘_bin’, which may then be used as input for later 
pipelines. It is recommended that the overlay image is 
used for quality assessment. Besides the obvious quality 
criteria such as alignment of segmentations to underly-
ing structures, pipeline-specific quality criteria are noted 
in the corresponding pipeline section. If a segmentation 
result is found deficient, the problematic filter in the 
pipeline has to be identified. For this purpose, each filter 
within a pipeline produces an intermediate result, which 
is named according to the filter. Based on these inter-
mediate results, filter parameters have to be adjusted to 
improve segmentation quality. Afterwards, the pipeline 
has to be executed again, and the quality assessment and 
parameter adjustment procedure is iterated. It is advisable 
to move the results obtained from earlier attempts into a 
subdirectory in order to examine the effect of the param-
eter adjustments. Otherwise, the results of earlier attempts 
will be overwritten.
The described procedure may have to be repeated sev-




1. Open the image stack with image processing software 
(e.g. ImageJ).
2. split the channels.
3. convert each channel to grey-value 8-bit pixel preci-
sion and save as a tiff file.
Pre-processing
contrast limited adaptive histogram equalization 
(clAHE):
In most cases, image stack quality in terms of brightness 
and contrast can be improved by the application of an algo-
rithm for contrast and brightness equalization and enhance-
ment. The following steps should be applied to each of the 
channels that will be used for further segmentation steps 
(DAPI, DPPIV, DMs):
1. select the pipeline ‘clAHE’.
2. specify the file location of the channel that has to be 
processed.
3. Use the default parameterization in an image stack 
set-up as described above. Include the following the 
parameters:
3.1 ‘Histogram Window size’ specifies the size of the 
window in 2D, respectively, the cuboid in 3D, in 
pixel/voxel for which an intensity histogram is 
compiled. The size should be larger than half the 
size of the features that are to be amplified. The 
larger the window, the longer the runtime.
3.2 ‘step size’ specifies the rate in pixel/voxel at 
which a new histogram window is calculated 
along each axis.
3.3 ‘clip level’ regulates the strength with which 
features are amplified. The parameter range is 
0–1, where 1 means that the algorithm behaves 
similarly to the adaptive histogram equalization 
(AHE) and thus produces the strongest amplifi-
cation. lower values will limit unwanted noise 
amplification. Values of 0.1 or smaller are reason-
able for many microscopy image set-ups, depend-
ing on the amount of background noise and inten-
sity of features.
4. After execution, a file is created in the same folder with 
the same name as the input file with the suffix ‘_clahe’.
Crop
In most cases, several first and last z-slides contain imaging 
artefacts (e.g. out-of-focus blur) and have to be discarded. 
To do so:
1. Open all channels after clAHE application with 
image processing software and identify the first and 
last z-slide that has no distortions in any channel.
2. select the pipeline ‘crop’.
3. specify the file location of the pre-processed channel. 
This pipeline processes one channel at a time.
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4. Enter the number of the first and last z-slide of sufficient 
quality in the fields ‘z start’ and ‘z end’. If image stacks 
differ in maximal x and y dimension from the default 
value, fill in the used dimension in ‘x end’ and ‘y end’.
5. After execution, a file will be created in the same folder 
with the same name as the input file with the suffix ‘_cut’. 
Note: crop each channel of an image stack using the 
same x, y and z bounds.
Troubleshooting: Normally, it is not necessary to apply 
clAHE to the Gs channel. However, if the Gs channel 




1. select ‘segment Necrotic region’ in the pipeline selec-
tion menu.
2. specify file locations of pre-processed DPPIV and 
DMs channels. The DPPIV channel will be used for 
result visualization only.
3. choose the threshold mode. The sample region size of 
the ‘Adaptive Otsu Threshold’ should be at least half 
the diameter of the largest necrotic region along the 
respective axis. The number of samples regulates at 
how many points within the dataset a sample region is 
constructed, and an individual Otsu Threshold is cal-
culated. More samples increase the processing time. 
The larger the sampling region, the fewer sampling 
points are needed. An alternative to the ‘Adaptive Otsu 
Threshold’ is the ‘Manual Threshold’ option, where a 
threshold for the whole image stack can be manually 
specified.
4. The first erosion dilation pair is for noise removal and 
closing of small cavities within the necrotic region. 
The dilation kernel size should be roughly twice the 
size of the erosion kernel size. The kernel sizes depend 
largely on the level of noise within the dataset.
5. The second erosion dilation pair is for the removal of 
sinusoidal structures. Therefore, kernel size of the ero-
sion operator should be slightly larger than the sinusoi-
dal radius (in pixel). The kernel size of the dilation oper-
ator should be slightly larger than the erosion kernel to 
close the remaining cavities within the necrotic region.
6. remove small isolated objects. In the preceding step, 
most of the sinusoidal system was removed. However, 
the complete structure may not have been removed by 
the erosion operator if very thick sinusoids and branch-
ing structures were present. Therefore, in this step, all 
objects below a certain volume will be removed. Adjust 
the volume, in case of very small necrotic regions (e.g. 
at dataset borders).
7. After execution using the DPPIV and DMs channel 
and files beginning with the prefix ‘necroticregion’, 
the segmentation is saved as a binary mask and two 
overlay images.
Note:  The boundaries of the segmented necrotic region 
should match the image data, as they will be used for dis-
tance measures. Holes within the segmented necrotic 
region are tolerable and sometimes inevitable due to the 
lack of DMs signal.
Vein segmentation
1. select ‘segment Veins’ in the pipeline selection menu.
2. specify file locations of the pre-processed DPPIV, 
DMs and (optionally) DAPI channels.
3. Find for each channel an intensity threshold that delim-
its the lumen of the veins as completely as possible 
using image processing software.
4. The opening radius is determined by the radius of the 
lumen of the largest attached blood vessel that should 
not be part of the vein segmentation.
5. The closing radius is determined by the radius of the 
largest object in the vein lumen. The signals of mac-
rophages, erythrocytes or other cells remaining in the 
lumen of the vein during imaging will thereby not 
compromise segmentation.
6. select ‘seed Point selection’ below the parameter table 
to open the point selection window.
6.1 Place a marker in the lumen of each central vein. 
click ‘Finish cV seed Point selection’.
6.2 Place a marker in the lumen of each portal vein. 
click ‘Finish PV seed Point selection’.
6.3 click ‘Finish seed Point selection’. The seed 
point selection window will close, and the pipe-
line is ready to be started.
7. After execution, the segmentation of central and por-
tal veins is saved as a binary mask and overlay images 
in files beginning with the prefix ‘vein_central’ and 
‘vein_portal’, respectively.
Critical step: seed point selection window handling:
1. Browse the stack using the up and down arrow keys. In 
the lower left corner, the slide number is shown.
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2. Enter/Quit a seed point marker input mode by pressing 
the ‘s’ key.
3. While in input mode, seed points can be positioned at 
the image plane using the left mouse button. Placed 
seed points can be dragged. The last placed seed point 
can be deleted by pressing the ‘Delete’ key.
Troubleshooting: It is crucial to identify the appropriate 
thresholds. Use thresholds that define the margin of the 
lumen as completely as possible. Two, if necessary three, 
channels can be used to reconstruct the veins. Holes in 
the endothelium that are present in all two/three threshold 
channels may result in erroneous reconstruction of veins, 
because boundary information is missing. In this case, 
larger opening and/or smaller closing radii may help.
Note Boundaries of the segmented veins must match with 
the image data, as they will be used for distance measures.
sinusoid and Bile canaliculi segmentation
 1. select ‘segment sinusoids + Bile canaliculi in 60× 
Datasets’ in the pipeline selection menu.
 2. specify file locations of the pre-processed DPPIV 
and DMs channels. In case the image stack contains 
necrotic tissue, check the ‘Is there a necrotic region’ 
box and specify the necrotic region segmentation file. 
Adjust voxel spacing settings if the image set-up dif-
fers from the default values.
 3. select threshold modes for segmentation of sinu-
soids in DPPIV and DMs channels. recommended 
is the ‘Adaptive Otsu Threshold’. some datasets may 
require the specification of a manual threshold. A 
voxel needs to pass thresholds in both channels to be 
considered a sinusoidal voxel, which helps minimize 
false positives. However, locally impaired intensity of 
one channel may prevent correct segmentation; there-
fore, careful threshold tuning is mandatory.
 4. remove noise artefacts. For the removal of very small 
artificial objects due to ‘salt-and-pepper noise’ an 
inverse hole-filling operator is applied. radii should 
not exceed 3 pixel. Majority threshold values have to 
be within the range of 0–10. The smaller the value, 
the stronger the noise reduction effect, where values 
smaller than 2 may also remove some boundary vox-
els of larger objects.
 5. Fill cavities within sinusoids. It is recommended to 
use the accelerated (and less precise) version of the 
algorithm. set the radius to a value slightly larger than 
the largest cavity. In case there are holes that are not 
completely surrounded by segmented voxels, increase 
the ‘minimal fraction of surrounding foreground’ 
value and decrease this value once artificial contacts 
are introduced. It is recommended to use the ‘acceler-
ated’ version.
 6. close the remaining cavities and discontinuities and 
remove small artificial objects. The closing radii 
should equal the largest remaining cavity radii. Open-
ing radii should be slightly larger than radii of the 
largest artificial objects.
 7. remove isolated objects. All isolated objects of a vol-
ume smaller will be removed.
 8. remove noise in the DPPIV channel prior to the bile 
canaliculi segmentation. In case of high noise lev-
els in the DPPIV channel, the median and greyscale 
opening radii might be increased to a maximum value 
of 2.
 9. select a threshold mode for segmentation of bile cana-
liculi in DPPIV channel. recommended is the ‘Adap-
tive Otsu Threshold’. some datasets may require a 
manual threshold. since in this step the focus is on 
the bile canaliculi, the method and/or value may differ 
from the one used in step 4.
 10. close cavities and small discontinuities. The radii 
of the hole-filling operator should not exceed 2. The 
majority value should be smaller than 4 to ensure the 
closing of very small gaps. smaller majority values 
may result in additional boundary voxels. Make sure 
that branching points are still clearly defined.
 11. removal of artificial objects. There are three steps in 
the noise removal process. The opening may affect 
segmented bile canaliculi if their radius is in the range 
of the opening radius. In this case, skip the opening 
by using the default radius value of 0. small artifi-
cial objects will be removed by inverse hole filling. 
Proceed as in step 5. The final step in object removal 
will discard all objects with a volume smaller than the 
specified value.
 12. After execution, the segmentation of sinusoidal and 
bile canaliculi networks is saved as binary mask and 
overlay images in files beginning with the prefix 
‘sinus’ and ‘bile’, respectively. 
Note: It is critical that the segmented sinusoids and bile 
canaliculi appear as solid structures free from inner holes. 
Otherwise, the network parameters will be altered. segmen-
tation boundaries have to match the endothelial staining in 
the DPPIV/DMs channel as precisely as possible. Pay spe-
cial attention to the connectivity of the bile canaliculi net-
work. limit the number of artificial branch gaps, especially 
at intersections, to a minimum. Otherwise, the number of 
dead-end branches and intersections may be increased or 
decreased.
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Network graph extraction and analysis
 1. select ‘Extract and Analyze Graph’ in the pipeline 
selection menu.
 2. choose the network type from the drop-down menu. 
This is a convenience option that will determine the 
network type-dependent default parameters.
 3. choose the type of input from the drop-down menu. 
The ‘skeleton Image’ option will transform a skel-
eton image of a network into a graph representation 
and optionally visualize and analyse it. The ‘Graph’ 
option skips the transformation steps.
 4. Depending on the input type, specify the file location 
of the skeleton image or the first graph file (ending on 
the suffix ‘_graph0.txt’).
 5. Validate this for both network types using the follow-
ing parameters:
5.1 resampling filter: The transformation of a net-
work skeleton into a network graph produces 
a graph where vertices represent single voxels. 
Thus, graph edges have a length of single voxels. 
The re-sampling factor determines the fraction 
of vertices per branch that are kept. Intermediate 
vertices will be discarded. This procedure pre-
vents the quantification of artefacts.
5.2 remove dead-end filter: All dead-end branches of 
a length smaller than the threshold are considered 
artificial and will thus be discarded.
5.3 collapse intersection nodes filter: All intersection 
node paired within a distance smaller than the 
threshold are considered artificially separated and 
will thus be merged together.
5.4 Geometric pruning filter: Vertices that introduce 
a deviation from a straight line of less than this 
angle are considered obsolete for maintaining the 
geometrical structure of the graph and will thus 
be deleted. Instead of this vertex and the two 
attached edges, a direct edge between the two 
other edge defining vertices is introduced. This 
procedure is applied to vertices with exactly two 
attached edges.
 6. select whether an analysis of the network graph is 
desired.
 7. The ‘Output file prefix’ will be used as a prefix for the 
analysis files. It is recommended to use the default 
value.
 8. specify the dataset name. All quantified objects will con-
tain a reference to the dataset name in the analysis file.
 9. specify the file locations of the requested segmenta-
tion files.
 10. specify the voxel size in case it differs from the 
default values.
 11. Pipeline execution graphs will be visualized, if the 
‘Display Options’ are set accordingly. Graphs are 
saved in text files beginning with the prefix from point 
7. sub-graphs that are not connected are stored in 
individual, enumerated files.
Nuclei segmentation
 1. select ‘segment Nuclei in 60× Datasets’ in the pipe-
line selection menu.
 2. specify file location of the pre-processed DAPI chan-
nel. Adjust the voxel spacing according to the image 
setup.
 3. In case image data have high noise levels, increase the 
median filter and greyscale opening radii.
 4. choose a threshold mode. ‘Adaptive Otsu Threshold’ 
will yield superior results in most cases. In case of 
high noise levels or weakly stained structures of inter-
est, the results of the Otsu method may not be satisfy-
ing quality. Try to find a ‘Manual Threshold’ instead.
 5. remove ‘salt-and-pepper noise’ using ‘Inverse Hole 
Filling’. For high ‘salt-and-pepper noise’ levels, lower 
the ‘Majority Threshold’ and increase the radii. For 
low noise levels, the ‘Majority Threshold’ may be 
increased.
 6. close cavities in nuclei. set the radius to a value 
slightly larger than the largest cavities. In case of holes 
that are not completely surrounded by segmented vox-
els, increase the ‘minimal fraction of surrounding fore-
ground’ value and decrease this value if segmentation 
suffers from erroneously enlarged nuclei. It is recom-
mended to use the accelerated version.
 7. close any last remaining cavities that are not com-
pletely surrounded by segmented voxels. closing radii 
should be at least equal to the largest cavity radii. Too 
large radii may result in the artificial merging of sepa-
rated objects.
 8. remove small artificial objects that are few voxels in 
size using the opening operator. Too large opening 
radii may result in the artificial separation of objects.
 9. separate the artificially agglomerated nuclei. The 
‘alpha’ default value will be appropriate in most 
cases. smaller alpha values will result in more, 
whereas larger alpha values will result in less separa-
tion events.
 10. remove artificial objects and group nuclei. In this 
step, each object will be evaluated according to its 
diameter. All objects with a diameter smaller than 
‘smallest non-hepatocyte diameter’ will be dropped. 
remaining objects are classified according to their 
diameter as non-hepatic or hepatic nuclei. In case the 
‘biggest non-hepatocyte diameter’ exceeds the ‘small-
est hepatocyte diameter’, nuclei with a diameter in 
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this overlapping range will be classified according 
to their roundness measure, which ranges from 1 for 
spherical objects to 0 for infinitely elongated objects.
 11. After execution, the segmentation of hepatic and non-
hepatic nuclei is saved as binary mask and overlay 
images in files beginning with the prefix ‘hepNuclei’ 
and ‘non-HepNuclei’, respectively.
Note:  segmented nuclei should contain no inner holes 
and must be separated and classified correctly. separation 
of nearly spherical agglomerations of nuclei may fail in 
some cases.
Hepatocyte shape approximation
1. select ‘Approximate cell shape’ in the pipeline selec-
tion menu.
2. specify the dataset file list, ending with ‘.ias’. This will 
automatically fill in most of the necessary segmentation 
files. Fill in the DPPIV channel, check the necrotic region 
check box if necessary and fill in the voxel spacing.
3. It is advisable to use the default parameterization in an 
image stack set-up as described above. Adjust the fol-
lowing:
3.1 ‘Bile weight’ is a measure which balances the 
influence of bile canaliculi and sinusoids on the 
one hand and nuclei on the other, with respect 
to the cell shape approximation. The parameter 
range is 0–1, with 0 representing full emphasis on 
nuclei, ignoring the bile canaliculi and sinusoids, 
and 1 representing the contrasting situation.
3.2 As in the nuclei segmentation pipeline, the 
‘alpha’ regulates the number of objects that will 
be produced. smaller alpha values will result in 
more, whereas larger alpha values will result in 
less individual cells.
3.3 cells without nuclei and cells with diameters 
smaller than ‘Minimal cell diameter’ are consid-
ered artificial and will be discarded.
4. After execution, the cell shape approximation results 
are saved as binary mask and overlay images in files 
beginning with the prefix ‘cellshape’.
Note:  It is critical that boundaries of approximated hepat-
ocytes align with confining structures. Artefacts in sinu-
soid or bile canaliculi segmentation may lead to incorrect 
cell boundaries. At dataset borders, cell boundaries may be 
incorrect due to incomplete confinement information. These 
artefacts can be ignored, since only inner cells that are not 
in contact with dataset borders are used for quantification.
Hepatocyte analysis
1. select ‘Analyze cells’ in the pipeline selection menu.
2. specify the dataset name. All quantified objects will 
hold a reference to the dataset name in the analysis file.
3. specify the dataset file list ending on ‘.ias’. This will 
create a parameter table with all necessary segmenta-
tion files.
4. In case of a different voxel size, amend the voxel spac-
ing parameters.
How to handle data with different image settings
The effective voxel size of our datasets was 
0.207 μm × 0.207 μm × 0.54 μm. The default parameter 
values of all pipelines are dependent on this dataset set-up.
In case the voxel size differs due to e.g. different mag-
nification or voxel resolution, all kernel values have to 
be rescaled. For example, a closing operator using a ker-
nel of size 2, 2, 1 in our set-up would use a rescaled 
kernel of size 4, 4, 1 in a set-up with voxel sizes of 
0.414 μm × 0.414 μm × 0.54 μm. However, this rule of 
thumb is only applicable when the feature appearances 
of all structures of interest to be segmented are similar 
in appearance to our setup. If this prerequisite is not met 
(e.g. due to lower magnification where sinusoids appear as 
solidly stained structures, rather than stained endothelial 
cells that encircle a stain-free lumen), necessary parameter 
adjustments might be less straightforward; and in extreme 
cases, the pipelines may not be applicable.
Modelling based on TiQuant
In the upcoming open-source software framework cellsys, 
the quantifications obtained from TiQuant can directly be 
used as an input for the cellsys modelling engine. As an 
illustration of this application of the processing pipeline, 
we refer to a model of liver regeneration after ccl4-induced 
liver damage. This model correctly predicted a previously 
unknown and subsequently experimentally validated order 
mechanism that was found essential for liver regeneration 
(Hoehme et al. PNAs 2010).
Tissues of mouse, human and pig liver
Mouse liver tissues used for the current stainings were 
obtained from: (1) c57Bl6/N mice, 8–12 weeks old, male 
(charles rivers, sulzfeld, Germany) and (2) DPPIV/cD26-
deficient mice were generated by re-derivation of mice 
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(c57Bl/6-DPPIVtm1Nwa/Orl) from a frozen stock at 
the European Mouse Mutant Archive (EMMA). The gene 
was inactivated by homologous recombination resulting in 
homozygous mice on the c57Bl/6 background with inac-
tive cD26 genes, both soluble and membrane bound (Mar-
guet et al. 2000); (3) β-catenin KO mice as described in our 
previous publication (Braeuning et al. 2010); and (4) the 
livers from 12-week-old BAlB/c-Abcb4−/− (MDr2 KO) 
animals were used to analyse the hepatic stellate cell mark-
ers. Pig liver tissue was obtained from 10- to 14-week-old 
female piglets (large White, common land race pigs, from 
INrA Jouy-en-Josas, France) weighting 28–42 kg at the 
time of 70 % liver resections. Human liver was obtained 
from the University Hospital of Jena. The local authori-
ties have approved the use of liver tissue from mice and 
pigs. The local ethical committee has approved analysis of 
human liver tissue for immunostaining.
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